Assistant Professor
PhD, University of Maryland School of Medicine; MPhil, Yale University; MPH, Yale University
Bloomberg School of Public Health
Molecular Microbiology and Immunology
Malaria Research Institute
- Plasmodium parasites, the causative agent of malaria, are transmitted to a vertebrate host by the infective bite of an Anopheles mosquito. Development of the parasite in the mosquito is an obligatory step in its life cycle and offers us an additional target in the effort to curb disease transmission.
-
-
Discovery of novel interventions in the fight against malaria requires a pioneering approach to examine cell-cell interactions among the transmission stages of the parasite (i.e., sporozoite and ookinete) and their respective mammalian or mosquito host cells. Glycobiology offers such a unique approach. In model systems, glycans and glycoconjugates have been shown to be important structural components of cell walls and the extracellular matrix, modifiers of protein solubility (secretion) and stability (protection from enzyme degradation), modulators of glycoprotein trafficking both intra- and extracellularly (e.g., by modifying porosity of the glycocalyx), mediators of cell-cell and cell-matrix adhesion and intra- and extracellular signaling. Yet, despite their clear importance in cell biology, an appreciation of glycan posttranslational modification of critical proteins involved in host-pathogen interactions, especially in the context of malaria parasite development, remains undervalued.
-
In addition to using transgenic technologies (parasite) and RNAi (mosquito), we are also applying mass spectrometry and lectin/glycan arrays to answer some of the fundamental questions concerning how protein-glycan interactions mediate cell invasion across different parasite developmental stages (but most especially in the mosquito). Recent and on-going work have examined the role of glycosyltransferases, glycoconjugates (glycoproteins and proteoglycans) on the mosquito midgut surface as well as identified novel ookinete (parasite) lectin-like molecules.
-
-
Microbial pathogens have been shown to subvert normal host cell glycoconjugates for initial attachment and subsequent invasion. The working hypothesis is that cell adhesion/invasion is believed to be co-receptor mediated, wherein initial adhesion and recognition of the host cell membrane is achieved through protein-glycan recognition and invasion entails recognition of a second ligand, such as a host cell surface protein. My work, along with several others, has contributed greatly to the body of knowledge on the characterization of mosquito midgut carbohydrate ligands for Plasmodium ookinetes. To date, several protein and glycans have been identified as potential transmission-blocking vaccine candidates. We continue to dissect the role of protein-glycan interactions during midgut invasion that, in turn, can lead to the discovery of new adhesion ligands and adhesins on the mosquito midgut and ookinete, respectively. Implicit in this thrust is the development of a pan-malaria transmission-blocking vaccine, a goal of considerable interest to several multilateral malaria vaccine initiatives. In fact, antibodies against one anopheline midgut antigen, a membrane alanyl aminopeptidase (APN) have been tested in standard membrane feeding assays in both Cameroon and Thailand to assess their efficacy in blocking the development of naturally circulating strains of Plasmodium falciparum. and Plasmodium vivax. The results suggest that the concept of a pan-malaria mosquito-based transmission-blocking vaccine may be viable. Feasibility studies that may ultimately lead to process development of this mosquito antigen as a vaccine target are underway.
-
However, inherent limitations exist with the use of mosquito midgut antigens as transmission-blocking vaccine targets. First and foremost is the lack of natural boosting since the human immune system will not be exposed to mosquito midgut antigens. Given this problem, in collaboration with Dr. Hai-Quan Mao (JHU Biomedical Engineering), we have been applying the use of biodegradeable micro and nanoparticle technology as a platform for temperature-stable (no cold chain necessary), single-immunization (slow antigen release), needle-free vaccine delivery.
-
-
Jennifer Armistead (PhD student)
-
Catherine de Beaumont (ScM student)
-
Panadda Krairojananan (PhD student, Mahidol, Thailand)
-
Melissa Zarr (PhD student, SOM)
-
-
Zeinab Annan
-
Ceereena Mohien
-
Lindsay Parish
-
David Colquhoun (Proteomics Specialist)
- Glycobiology, Malaria, Transmission-blocking vaccine, Vector Biology; Plasmodium cell biology; Proteomics
- NIAID Research Scholar Development Award (K22), NIH
-
Ruth L. Kirschstein National Research Service Award, NIAID, NIH
-
Pfizer Centennial Travel Award, ASTMH
-
HHMI/WHO-TDR/BioMalPar Third Functional Genomics of Malaria Parasites Course Scholarship
-
First Place, 2nd Annual JHSPH Postdoctoral Fellows Research Poster Competition
-
Millipore Foundation Dmitri V. d'Arbeloff Postdoctoral Fellowship in the Biological Sciences
-
MacArthur Foundation, DVBID Scholarship for The Biology of Disease Vectors Course
-
John Perry Miller Fund Award for Graduate Dissertation Research, Yale University
Research Projects
Biodegradable Microparticles for Oral Delivery of a Malaria Transmission-Blocking Vaccine
The primary goal of this pilot project with Dr. Hai-Quan Mao (JHU Biomedical Engineering) is to develop an efficient biodegradable microparticle (BMP) system that provides sustained release of a malaria transmission-blocking AgAPN1 antigen, and then determine the efficacy of this BMP vaccine...
Feasibility Program (Phase I) Malaria Transmission-Blocking Vaccine
Feasibility study for the development of a mosquito based malaria transmission-blocking vaccine.
Glycobiological Analysis of Plasmodium-Vector Host Interactions
An understanding of not only protein-protein but protein-glycan interactions are needed before we can completely dissect the molecular mechanisms involved in Plasmodium ookinete invasion of the mosquito midgut. Objectives: Functional analyses of
mosquito midgut glycoconjugates during Plasmodium...
Plasmodium carbohydrate receptors in Anopheles gambiae
Carbohydrates and carbohydrate-binding proteins not only inhibit parasite attachment to the midgut brush border but completely block parasite development as well. Since the identity of the full range of polypeptide backbones that can bear these glycans is unknown, specific protein targeting is...
Small Molecule Protein-Glycan Inhibitors as Malaria Transmission-Blocking Therapeutics
Malaria transmission entails development of the Plasmodium parasite in the mosquito. We have identified a critical interaction between an unknown ookinete lectin-like protein and a chondroitin sulfate glycosaminoglycan ligand on the mosquito midgut lumenal surface. We hypothesize that by...
-
González-Lázaro M., Dinglasan, R.R., de la Cruz Hernández-Hernández, F., Rodríguez, M.H., Jacobs-Lorena, M. Flores-Romo, L. Anopheles gambiae Croquemort SCRBQ2, expression profile in the mosquito and its potential interaction with the malaria parasite. Insect Biochem Mol Biol. 2009, 39(5-6): 395-402.
-
Vega-Rodriguez J., Franke-Fayard B.**, Dinglasan R.R.**, Pastrana-Mena R., Rodriguez-Orengo J., Delgado W., Waters A.P., Janse C., Jacobs-Lorena M., and Serrano A.E. The glutathione biosynthetic pathway is essential for Plasmodium berghei sporozoite development in the mosquito. PLoS Pathog. 2009 5(2):e1000302.
-
Dinglasan, R.R.*, Devenport, M.*, Florens, L., Johnson, J.R., Carucci, D., Yates, J.R., Jacobs-Lorena, M. The Anopheles gambiae mosquito midgut adult peritrophic matrix 1 proteome. Insect Biochem Mol Biol. 2009, 39(2):125-34.
-
Dinglasan R.R., Alaganan, A., Ghosh, A. K., Saito, A., van Kuppevelt, T.H., Jacobs-Lorena, M. Plasmodium falciparum Ookinetes Require Mosquito Midgut Chondroitin Sulfate Proteoglycans for Cell Invasion. PNAS 2007, 104 (40): 15882-15887.
-
Dinglasan R.R., Kalume, D.E., Kanzok, S.M., Ghosh, A.K., Muratova, O., Pandey, A., Jacobs-Lorena, M. Disruption of Plasmodium falciparum development by antibodies against a conserved mosquito midgut antigen. PNAS 2007, 104 (33): 13461-13466.
-
Porter-Kelley, J.M., Dinglasan, R.R., Alam, U.A., Azad, A.F. Axenic In vitro Development of Mosquito Phases of the Malaria Parasite, Plasmodium yoelii is a potential attenuated sporozoite vaccine candidate. Exp Parasit 2006, (112): 99-108.
-
Dinglasan, R.R., Porter-Kelley, J.M., Alam, U., Azad, A.F. Peptide mimics of mosquito midgut carbohydrate antigens as malaria transmission blocking vaccine candidates. Vaccine 2005, Vol 23(21): 2717-2724.
-
Dinglasan R.R., Valenzuela, J.G., Azad, A.F. Sugar Epitopes as Potential Universal Disease transmission blocking targets. Insect Biochem. Mol. Biol. 2005, 35(1): 1-10.
-
Dinglasan, R.R., Shahabuddin, M., Fields, I., Azad, A.F., Sacci, J.B. Monoclonal Antibody MG96 Completely Blocks Plasmodium yoelii Development In Anopheles stephensi. Infect Immun. 2003, 71(12):6995-7001.
-
-
Dinglasan, R.R., Jacobs-Lorena, M. Flipping the Paradigm on Malaria Transmission-Blocking Vaccines.Trends Parasit. 2008 24(8):364-70.
-
Dinglasan, R.R., Jacobs-Lorena, M. Insight Into A Conserved Lifestyle: Protein-carbohydrate adhesion strategies for vector-borne pathogens. Infect Immun. 2005, 73 (12): 7797-7807.
|
|
